Document is current

Any future updates will be listed below

Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study

Crossref DOI link: https://doi.org/10.1245/s10434-024-15886-6

Published Online: 2024-07-18

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark